Edition:
United Kingdom

Alder Biopharmaceuticals announces commencement of public offering of common stock


Tuesday, 11 Jul 2017 

July 11 (Reuters) - Alder Biopharmaceuticals Inc :Alder Biopharmaceuticals, Inc. announces commencement of public offering of common stock.Alder Biopharmaceuticals Inc - Intends to offer and sell, 12.5 million shares of its common stock in an underwritten public offering.Alder Biopharmaceuticals - Intends to use net proceeds from offering, to fund continued development of eptinezumab, among the others. 

Company Quote

10.83
-0.15 -1.37%
17 May 2019